In today’s briefing:
- Guotai Junan (1788 HK): Get Involved Here
- MS-China Sep 2026 Index Rebalance Forecast
- On Swire (19 HK)’s 2026 Interim Results. Still Inexpensive
- Pre-IPO Ingenic Semiconductor (PHIP Updates) – Some Points Worth the Attention
- IPO WATCH: Unitree Robotics – One Small Step for Man, One Giant Leap for Humanoids
- IPO Databook: Ingenic Semiconductor (HK) – Aug 2026
- Hong Kong Single Stock Options Weekly Aug 03–07: Day-Of-Week Pattern Emerges as Volumes and Vol Fall
- Aequitas: Hubei Dinglong A/H Listing – Astute Expansion Prior Years; YMTC Might Be Largest Customer
- Suzhou Genhouse Bio (SGHB HK): Synthetic Expert Call Transcript (10 Aug 2026)
- Zhejiang Energy Marine Environmental Technology (ZJEME HK): Synthetic Expert Call Transcript (10 Aug 2026)
Guotai Junan (1788 HK): Get Involved Here
- After broker/investment bank Guotai Junan (1788 HK) (GJI) was suspended last month pursuant to the Takeover’s Code, an Offer from its state-backed parent Guotai Haitong (601211 CH) (GHS) was expected.
- That unfolded last Friday evening (7th July), with GHS pitching a pre-conditional (SASAC/NDRC) Scheme at HK$3/share, a 44.2% premium to last close, bang in-line with my estimate. Terms are final.
- The pre-con long stop date is the 31st October. That’s uncommonly quick. This could (should) be wrapped up before year-end. Plus there are some quirky Scheme vote-blocking %s.
MS-China Sep 2026 Index Rebalance Forecast
- We screen China stocks ahead of a global index’s August 2026 quarterly review, with 16 ADD and 22 DELETE candidates.
- Nine of 16 ADD candidates are Information Technology names, and six cleared the May cutoffs without being added.
- The DELETE list splits into 12 names below the retention lines across the full cutoff range and 10 borderline names.
On Swire (19 HK)’s 2026 Interim Results. Still Inexpensive
- Swire Pacific (19 HK)‘s 1H26 reported profit was HK$6.8bn versus HK$815mn in 1H25.
- 83%-Held Swire Properties (1972 HK) reported profit of HK$3.6bn vs. a loss of HK$1.2bn in 1H25. 45.12%-held Cathay Pacific (293 HK) reported a 71% increase in underlying profit of HK$6.2bn.
- Note: short interest in Cathay, one the best performing global airlines over the past year (in terms of share price), has picked up since the end of May.
Pre-IPO Ingenic Semiconductor (PHIP Updates) – Some Points Worth the Attention
- Different business models have led to a divergence in the profit logic of enterprises. Compared with IDH manufacturers such as Samsung/Micron, Ingenic has demonstrated unique advantages during price increase cycle
- Capacity constraints and differences in business models will pose challenges to Ingenic’s sustained profitability.How to strike a balance between reliance on contract manufacturing and market expansion is the core issue.
- The scarcity of automotive-grade storage and Ingenic’s leading position may lead to a valuation premium. A comfortable P/E range could be 60-80x, based on 2026 net profit forecast.
IPO WATCH: Unitree Robotics – One Small Step for Man, One Giant Leap for Humanoids
- Chinese robot maker Yushu Technology (Unitree Robotics, 688836 CH Equity) priced its initial public offering (STAR market) in a deal that would make it the first mainland-listed humanoid robot manufacturer.
- The retail portion was 8,000x oversubscribed with 9.8 million individual investor orders, marking a landmark moment for China’s embodied-AI sector. China’s global market share in humanoid robots is >85%.
- The nearest listed competitor is UBTECH Robotics (9880 HK); however, Agibot, the world’s largest humanoid robot company by unit sales, is slated to list on the Shanghai exchange soon.
IPO Databook: Ingenic Semiconductor (HK) – Aug 2026
- Ingenic Semiconductor Co., Ltd. is a fabless IC provider specializing in memory, computing, and analog ICs for various devices. It holds leading market positions in niche DRAM, SRAM, NOR Flash,.
- Ranked 7th globally in Niche DRAM and NOR Flash, and 2nd in SRAM and IP-Cam SoC by 2025 revenue. 1x-nm LPDDR4 products entered mass production.
- FY2025 revenue was 4,741,008. Net margin decreased from 11.4% (2023) to 7.9% (2025). Gross margin decreased from 35.5% (2023) to 32.8% (2025).
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Hong Kong Single Stock Options Weekly Aug 03–07: Day-Of-Week Pattern Emerges as Volumes and Vol Fall
- Hong Kong equities paused after a strong run, with market breadth weakening despite a continued upside skew in individual stock returns.
- Single stock option activity fell sharply, with weaker Call trading accounting for much of the decline.
- HSI implied volatility remains subdued relative to its recent history, while single stock implied vols remain comparatively elevated.
Aequitas: Hubei Dinglong A/H Listing – Astute Expansion Prior Years; YMTC Might Be Largest Customer
- Hubei Dinglong (HDLNG HK) , aims to raise at least US$750m in its H-share listing.
- It provides upstream integrated materials and solutions for the semiconductor and other high-tech industries in response to the broad and growing demand for supply chain localization and technology roadmaps.
- In this note, we look at its past performance and other deal dynamics that might impact the listing.
Suzhou Genhouse Bio (SGHB HK): Synthetic Expert Call Transcript (10 Aug 2026)
- Gilead’s $80 million upfront payment for MAT2A inhibitor GH31 validates Genhouse’s synthetic lethality platform but creates a critical strategic divergence: Genhouse has surrendered global commercial rights to its most promising near-term asset, leaving its domestic pipeline heavily reliant on the highly competitive and crowded RAS-MAPK pathway.
- The company’s lead asset, SHP2 inhibitor GH21, faces immense clinical headwinds as a monotherapy, exhibiting a weak objective response rate with only 1 patient achieving a confirmed partial response out of 60 assessable patients in Phase 1 data, forcing a total strategic shift toward combination trials with KRAS G12C inhibitors like D-1553.
- Genhouse’s balance sheet remains highly constrained despite recent cash inflows. While the company closed a RMB 300 million crossover round in January 2026 and filed its HKEX IPO prospectus on August 7, 2026, its reported cash balance of RMB 98.27 million as of May 31, 2026, highlights rapid cash burn and the urgent need to clear historical net current liabilities of RMB (592.34) million.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.
Zhejiang Energy Marine Environmental Technology (ZJEME HK): Synthetic Expert Call Transcript (10 Aug 2026)
- Extreme Customer Concentration: Zhejiang Energy Marine’s recent Hong Kong IPO prospectus, filed on August 7, 2026, reveals that MSC Group represented 68% of its revenue in the first five months of 2026. This extreme concentration severely limits the company’s pricing independence and leaves its hyper-growth narrative highly vulnerable to a single commercial relationship.
- Regulatory-Driven Peak Demand Window: The current green equipment wave is tightly bound to EU ETS maritime integration (reaching 100% emissions coverage in 2026) and FuelEU Maritime compliance. However, this retrofit-heavy cycle is structurally temporary; the expert anticipates scrubber retrofit demand will peak around 2027 to 2028 before rapidly transitioning to dual-fuel newbuild orders.
- Mixed-Ownership Operational Agility: Unlike traditional rigid State-Owned Enterprises (SOEs), ZEME’s management holds a combined indirect equity stake of 45.8% through Dizuan Maritime and Hangzhou Xiling. This mixed-ownership reform aligns leadership incentives and enables exceptional operational execution—such as delivering single-vessel retrofits in 33 to 49 days versus the 60-day industry standard—while still utilizing the parent group’s state-backed credit.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.

